MANGOCEUTICALS, INC.
15110 N. Dallas Parkway, Suite 600
Dallas, Texas 75248
September 3, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Abby Adams
| Re: | Mangoceuticals, Inc. | |
Registration Statement on Form S-1 Filed August 16, 2024 | ||
| File No. 333-281617 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mangoceuticals, Inc., hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form S-1 so that it will become effective at 4:30 p.m., Eastern Daylight Time, on Thursday, September 5, 2024, or as soon thereafter as practicable.
| Very truly yours, | ||
| /s/ Jacob D. Cohen | ||
| Jacob D. Cohen | ||
| Chairman and Chief Executive Officer |
| cc: | Lucosky Brookman LLP |